Method of decreasing cutaneous senescence

Details Method of decreasing cutaneous senescence Method of decreasing cutaneous senescence

1994-08-08

1997-04-08

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Cosmetic, antiperspirant, dentifrice

530399, A61K 3766

Patent

active

056185448

ABSTRACT:
The appearance of human skin is improved, e.g., epidermal cell, and thereby cutaneous senescence is decreased, by topically administering to human skin an effective amount of a composition comprising a mixture of protein growth factors consisting essentially of (a) epidermal growth factor (EGF) and (b) a member selected from the group consisting of transforming growth factor-alpha (TGF-.alpha.), fibroblast growth factor (FGF) and a mixture of transforming growth factor-alpha (TGF-.alpha.) and fibroblast growth factor (FGF), in a cosmetically acceptable carrier.

REFERENCES:
patent: 4533635 (1985-08-01), Saglier et al.
patent: 4604234 (1986-08-01), Fuiji et al.
patent: 4670257 (1987-06-01), Saglier et al.
patent: 4808402 (1989-02-01), Leibovich et al.
patent: 4832946 (1989-05-01), Green
patent: 4839164 (1989-06-01), Smith
patent: 4843063 (1989-06-01), Seyedin et al.
patent: 4929442 (1990-05-01), Powell
patent: 4959353 (1990-09-01), Brown et al.
patent: 5023090 (1991-06-01), Levin
patent: 5064655 (1991-11-01), Uster et al.
patent: 5104977 (1992-04-01), Sporn et al.
patent: 5130298 (1992-07-01), Cini et al.
patent: 5219998 (1993-06-01), Levin et al.
PN JP5043442A-Abstract: Skin Cosmetic Material Contains a Basic Fibroblast Growth Factor Prevent Skin Age, Hayashibara et al., 1993.
Derwent Ab: 104, 1986: 104:192928u; 104:173476h; 116:241736p; 106182467v; 117:219741k; 115:176096t.
Derwent abstract for JP 5,043,442.
Chemical Abstracts 10422:19298u for JP 6,105,006.
Chemical Abstracts 10622:182467v for JP 6,219511.
Chemical Abstracts 10420:174376h for JP 6,115,810.
Chemical Abstracts 11624:241736p for JP 429.916.
Chemical Abstracts 11722:219741k for JP 4,145,100.
Chemical Abstracts 11517:176096t for Fragrance, 19(7):99-102 (1991).
Kawammoto et al. "Transforming growth factor type beta stimulates epidermal growth factor-dependent cell growth of in vivo and in vitro senescent human skin fibroblast." Cell Structure Functions (1988) 13(6):616.
Hollenberg et al., "Receptors for insulin and epidermal growth factor-urogastrone in adult human fibroblasts do not change with donor age," Mech. Ageing Dev. 11(1) (Aug. 1979).
Allen, Sir G., "Cosmetics--chemical technology or biotechnology?" International J. Cos. Sci. 6(12) (Apr. 1984).
Chua et al., "Receptor for epidermal growth factor retains normal structure and function in aging cells," Mech. Ageing Dev. 34(1):35-55 (Mar. 1986).
Brown et al., "Enhancement of wound Healing by Epidermal Growth Factor: An Initial Clinical Report," New England Journal of Medicine, 321:76-79 (1989).
Brown et al., "Stimulation of Healing of Chronic Wounds by Epidermal Growth Factor," Plastic & Reconstructive Surgery, 88:189 (1991).
Brown et al., "Acceleration of Tensile Strength of Incisions Treated with EGF and TGF-beta," Annals of Surgery, 208(6) 788-794 (1988).

Affiliated with

Also associated with

Rating

Method of decreasing cutaneous senescence does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of decreasing cutaneous senescence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of decreasing cutaneous senescence will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2396519